These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35809412)

  • 1. In-silico screening and in-vitro assay show the antiviral effect of Indomethacin against SARS-CoV-2.
    Chakraborty R; Bhattacharje G; Baral J; Manna B; Mullick J; Mathapati BS; Abraham P; J M; Hasija Y; Ghosh A; Das AK
    Comput Biol Med; 2022 Aug; 147():105788. PubMed ID: 35809412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Assessment of the Antiviral Activity of Ketotifen, Indomethacin and Naproxen, Alone and in Combination, against SARS-CoV-2.
    Kiani P; Scholey A; Dahl TA; McMann L; Iversen JM; Verster JC
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33810356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural interactions of phytoconstituent(s) from cinnamon, bay leaf, oregano, and parsley with SARS-CoV-2 nucleocapsid protein: A comparative assessment for development of potential antiviral nutraceuticals.
    Husain I; Ahmad R; Siddiqui S; Chandra A; Misra A; Srivastava A; Ahamad T; Khan MF; Siddiqi Z; Trivedi A; Upadhyay S; Gupta A; Srivastava AN; Ahmad B; Mehrotra S; Kant S; Mahdi AA; Mahdi F
    J Food Biochem; 2022 Oct; 46(10):e14262. PubMed ID: 35796388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review on
    Cetin Y; Aydinlik S; Gungor A; Kan T; Avsar T; Durdagi S
    Curr Med Chem; 2022; 29(38):5925-5948. PubMed ID: 35761502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Review on Screening Models for Potential Therapeutic Candidates and Targets Against SARS-CoV-2.
    Das M; Kumar M; Jha A; Madhukiran DR; Bharti K; Mondal S; Mishra B
    Curr Drug Targets; 2021; 22(11):1232-1254. PubMed ID: 33371846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19: Potential Repurposing Drugs.
    Leowattana W
    Infect Disord Drug Targets; 2022; 22(1):e110122191924. PubMed ID: 33645490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indomethacin has a potent antiviral activity against SARS coronavirus.
    Amici C; Di Caro A; Ciucci A; Chiappa L; Castilletti C; Martella V; Decaro N; Buonavoglia C; Capobianchi MR; Santoro MG
    Antivir Ther; 2006; 11(8):1021-30. PubMed ID: 17302372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants.
    Iaconis D; Bordi L; Matusali G; Talarico C; Manelfi C; Cesta MC; Zippoli M; Caccuri F; Bugatti A; Zani A; Filippini F; Scorzolini L; Gobbi M; Beeg M; Piotti A; Montopoli M; Cocetta V; Bressan S; Bucci EM; Caruso A; Nicastri E; Allegretti M; Beccari AR
    Cell Death Dis; 2022 May; 13(5):498. PubMed ID: 35614039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidating host cell response pathways and repurposing therapeutics for SARS-CoV-2 and other coronaviruses.
    Shen Z; Halberg A; Fong JY; Guo J; Song G; Louie B; Luedtke GR; Visuthikraisee V; Protter AA; Koh X; Baik T; Lum PY
    Sci Rep; 2022 Nov; 12(1):18811. PubMed ID: 36335206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.
    Alonzi T; Aiello A; Petrone L; Najafi Fard S; D'Eletto M; Falasca L; Nardacci R; Rossin F; Delogu G; Castilletti C; Capobianchi MR; Ippolito G; Piacentini M; Goletti D
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidating the Drug Repurposing Spectra of COVID-19 with its Analogues SARS and MERS.
    Mishra J; Prasun C; Sahoo PK; Nair MS
    Mini Rev Med Chem; 2021; 21(20):3191-3202. PubMed ID: 33632095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
    Abdurrahman L; Fang X; Zhang Y
    Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
    Froggatt HM; Heaton BE; Heaton NS
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19.
    Blaess M; Kaiser L; Sommerfeld O; Csuk R; Deigner HP
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Candidates against COVID-19 Targeting RNA-Dependent RNA Polymerase: A Comprehensive Review.
    Agrawal N; Goyal A
    Curr Pharm Biotechnol; 2022; 23(3):396-419. PubMed ID: 33882805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro.
    Hahn F; Wangen C; Häge S; Peter AS; Dobler G; Hurst B; Julander J; Fuchs J; Ruzsics Z; Überla K; Jäck HM; Ptak R; Muehler A; Gröppel M; Vitt D; Peelen E; Kohlhof H; Marschall M
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33291455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral Properties of the NSAID Drug Naproxen Targeting the Nucleoprotein of SARS-CoV-2 Coronavirus.
    Terrier O; Dilly S; Pizzorno A; Chalupska D; Humpolickova J; Bouřa E; Berenbaum F; Quideau S; Lina B; Fève B; Adnet F; Sabbah M; Rosa-Calatrava M; Maréchal V; Henri J; Slama-Schwok A
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33946802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kite-Shaped Molecules Block SARS-CoV-2 Cell Entry at a Post-Attachment Step.
    Chan SW; Shafi T; Ford RC
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indomethacin: an exploratory study of antiviral mechanism and host-pathogen interaction in COVID-19.
    Shekhar N; Kaur H; Sarma P; Prakash A; Medhi B
    Expert Rev Anti Infect Ther; 2022 Mar; 20(3):383-390. PubMed ID: 34633277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.